
MPE Newsletter | COVID-19 vaccination for myeloma patients
The SARS-CoV-2 (COVID-19) pandemic has raised a lot of questions, especially around vaccination. Myeloma Patients Europe (MPE) is working to respond some of the most frequently asked questions about the current approved vaccines in Europe and how they affect myeloma and AL amyloidosis patients. MPE has developed the Q&A “SARS-CoV-2 (COVID-19) Vaccination for Myeloma Patients” to cover the...